학술논문

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
Document Type
Article
Source
In: Arthritis Research and Therapy. (Arthritis Research and Therapy, December 2023, 25(1))
Subject
Language
English
ISSN
14786362
14786354